Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective
- Pashtoon M. Kasi
- , Hussein A. Tawbi
- , Chester V. Oddis
- , Hrishikesh S. Kulkarni
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- COVID-19 Researchers
- Division of Pulmonary & Critical Care Medicine
- Bursky Center for Human Immunology and Immunotherapy
- Siteman Cancer Center
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Molecular Cell Biology
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
Research output: Contribution to journal › Review article › peer-review
167
Link opens in a new tab
Scopus
citations